Change in 18F-Fluoromisonidazole PET Is an Early Predictor of the Prognosis in the Patients with Recurrent High-Grade Glioma Receiving Bevacizumab Treatment.
Bevacizumab (BEV), a humanized monoclonal antibody, become a currently important chemotherapeutic option for the patients with recurrent glioma. The aim of this retrospective study is to investigate whether 18F-Fluoromisonidazole (FMISO) PET have the potential to detect BEV-resistant gliomas in the...
Main Authors: | Shigeru Yamaguchi, Kenji Hirata, Takuya Toyonaga, Kentaro Kobayashi, Yukitomo Ishi, Hiroaki Motegi, Hiroyuki Kobayashi, Tohru Shiga, Nagara Tamaki, Shunsuke Terasaka, Kiyohiro Houkin |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5148016?pdf=render |
Similar Items
-
The Roles of Hypoxia Imaging Using <sup>18</sup>F-Fluoromisonidazole Positron Emission Tomography in Glioma Treatment
by: Kenji Hirata, et al.
Published: (2019-07-01) -
Successful Removal of a Metastatic Gastrointestinal Stromal Tumor in the Craniovertebral Junction using an Occipital Artery to Posterior Inferior Cerebellar Artery Bypass
by: Yukitomo Ishi, et al.
Published: (2014-05-01) -
Novel risk factors and management of brain sag after brain tumor surgery
by: Hiroaki Motegi, et al.
Published: (2021-03-01) -
Preoperative Texture Analysis Using <sup>11</sup>C-Methionine Positron Emission Tomography Predicts Survival after Surgery for Glioma
by: Osamu Manabe, et al.
Published: (2021-01-01) -
Hemorrhagic Onset of Hemangioblastoma Located in the Dorsal Medulla Oblongata Presenting with Tako-Tsubo Cardiomyopathy and Neurogenic Pulmonary Edema: A Case Report
by: Masayuki Gekka, et al.
Published: (2014-03-01)